List of Excipients in API hydralazine hydrochloride and isosorbide dinitrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydralazine hydrochloride and isosorbide dinitrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | ALUMINUM OXIDE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | ANHYDROUS LACTOSE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for hydralazine hydrochloride and isosorbide dinitrate
Excipient focus: ALUMINUM OXIDE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals | hydralazine hydrochloride and isosorbide dinitrate | 52536-006 |
| Bryant Ranch Prepack | hydralazine hydrochloride and isosorbide dinitrate | 72162-2343 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing ANHYDROUS LACTOSE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing CELLULOSE, MICROCRYSTALLINE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
hydralazine hydrochloride and isosorbide dinitrate drug variants containing FD&C YELLOW NO. 6
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing HYPROMELLOSE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing MAGNESIUM STEARATE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
hydralazine hydrochloride and isosorbide dinitrate drug variants containing POLYETHYLENE GLYCOL
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hydralazine hydrochloride and isosorbide dinitrate drug variants containing POLYSORBATE 80
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing SILICON DIOXIDE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydralazine hydrochloride and isosorbide dinitrate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
hydralazine hydrochloride and isosorbide dinitrate drug variants containing TITANIUM DIOXIDE
hydralazine hydrochloride and isosorbide dinitrate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
